Infectious Disease Testing Market Remains Dynamic Amid Post-Pandemic Shifts and New Innovations
The report also profiles emerging innovators bringing AI-powered diagnostics, rapid [...]
Alithea Genomics Launches MERCURIUS™ Total DRUG-seq: A Next-Generation Full-Length Transcriptome Profiling Platform for High-Throughput Compound Screening and Target Validation
“MERCURIUS Total DRUG-seq represents a new frontier in transcriptome-scale compound [...]
Exo Launches a New Era in Disease Diagnosis with the First FDA-cleared Ultrasound AI for Detection of Pleural Effusion and Consolidation/Atelectasis
Exo Iris® now automatically detects and localizes key pulmonary findings [...]
Backed by $2 Million, Droplet IV is Set to Launch its Revolutionary Automatic IV-Line Flushing Device in EU & US in 2026
Droplet IV today announced the successful completion of a $2 [...]
Expanding Innovations Receives FDA Clearance for N-GAGE™ Lumbar Plate System
The modular, low-profile construct offers spine surgeons a flexible fixation [...]
Cardiac Marker Testing Market Poised for Steady Growth, Driven by Point-of-Care Expansion
As cardiovascular disease remains a leading cause of mortality worldwide, [...]
City of Hope Awarded $23.7 Million to Map Biomarkers Linked to Treatment Resistance in Patients With Common Lung Cancer
The grant will help City of Hope create a bio [...]
Materna Medical Announces Ellora™ and Additional Close on $20M Series B2
The round welcomed new funds GLIN Impact Capital, Wealthing VC [...]
1Elevan Biopharmaceuticals Announces the Development of Its Next-Generation Peptide Therapeutics Headquarters in Fishers, Indiana
The new 133,500-square-foot headquarters at 12001 Exit 5 Parkway will [...]
Valar Labs’ CHAI Biomarkers Enhance Bladder Cancer Prediction | New Study in European Urology for Predicting Outcomes of High Grade Ta Bladder Cancer
The study finds that CHAI (Computational Histology AI) biomarkers stratify [...]